sulfamethoxazole has been researched along with Toxoplasmosis, Animal in 26 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of sulfamethoxazole (SMX) on experimental ocular toxoplasmosis by quantitative competitive polymerase chain reaction (QC-PCR) assay." | 7.73 | Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice. ( Aosai, F; Mun, HS; Norose, K; Yano, A, 2006) |
| "To evaluate the effects of sulfamethoxazole (SMX) on experimental ocular toxoplasmosis by quantitative competitive polymerase chain reaction (QC-PCR) assay." | 3.73 | Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice. ( Aosai, F; Mun, HS; Norose, K; Yano, A, 2006) |
| "To evaluate the effect of allicin alone or combined with SMZco on murine toxoplasmosis by a specific, rapid, and sensitive PCR technique." | 1.32 | [PCR in evaluating the effect of allicin and its combination with SMZco on murine toxoplamosis]. ( Liu, PM; Shan, LY; Yang, XZ, 2003) |
| " Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T." | 1.30 | Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998) |
| "Treatment with pyrimethamine and sulfamethoxazolum combination administered via intragastric route, was started 2 hours after each mouse received an intraperitoneal injection of a lethal inoculum of 5 x 10(3) tachyzoites of RH strain toxoplasma gondii and the therapy was lasted for 52 days." | 1.30 | [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice]. ( Ke, OY; Xiang, X; Zhang, Z, 1997) |
| " In the chronic cystogenic murine models, the combination TMP plus SMX administered from day 5 for 15 days or from day 28 for 288 days, gave protection and even apparent toxoplasmal eradication ('cure') at the highest dosing (60/300 mg/kg per day)." | 1.30 | Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models. ( Dumas, JL; Pechère, JC; Pizzolato, G, 1999) |
| "Five drug regimens for the treatment of acute toxoplasmosis were compared in a monkey model." | 1.27 | Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys. ( Harper, JS; London, WT; Sever, JL, 1985) |
| " By the suitable dosage the mortality rate could be reduced considerably." | 1.26 | [Experimental studies on the effect of the combination sulfamoxole/trimethoprim on the Toxoplasma infection of the mouse (author's transl)]. ( Maier, W; Piekarski, G, 1976) |
| "Trimethoprim was found to have no effect." | 1.25 | Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations. ( Seah, SK, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (65.38) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belal, US | 2 |
| Norose, K | 3 |
| Mohamed, RM | 2 |
| Sekine, S | 1 |
| Nukaga, T | 1 |
| Ito, K | 1 |
| Abdellatif, MZ | 1 |
| Abdelgelil, NH | 1 |
| Yano, A | 3 |
| Shan, LY | 1 |
| Yang, XZ | 1 |
| Liu, PM | 1 |
| Aosai, F | 2 |
| Mun, HS | 2 |
| Ahmed, AK | 1 |
| Chen, M | 1 |
| Piao, LX | 1 |
| Iwakura, Y | 1 |
| Fiorello, CV | 1 |
| Heard, DJ | 1 |
| Heller, HL | 1 |
| Russell, K | 1 |
| Nguyen, BT | 3 |
| Stadtsbaeder, S | 4 |
| Garin, JP | 1 |
| Paillard, B | 1 |
| Alder, J | 1 |
| Hutch, T | 1 |
| Meulbroek, JA | 1 |
| Clement, JC | 1 |
| Brun-Pascaud, M | 1 |
| Chau, F | 1 |
| Derouin, F | 1 |
| Girard, PM | 1 |
| Xiang, X | 1 |
| Ke, OY | 1 |
| Zhang, Z | 1 |
| Dumas, JL | 1 |
| Pizzolato, G | 1 |
| Pechère, JC | 1 |
| Grossman, PL | 1 |
| Remington, JS | 2 |
| Thiermann, E | 1 |
| Apt, W | 1 |
| Atias, A | 1 |
| Lorca, M | 1 |
| Olguín, J | 1 |
| Coradello, H | 1 |
| Kretschmer, S | 1 |
| Maier, W | 1 |
| Piekarski, G | 1 |
| Seah, SK | 1 |
| Hamadto, HH | 1 |
| Rashed, SM | 1 |
| Marii, NE | 1 |
| Sobhy, MM | 1 |
| el-Ridi, AM | 1 |
| el-Fakahany, AF | 1 |
| Harper, JS | 1 |
| London, WT | 1 |
| Sever, JL | 1 |
| Vischer, WA | 1 |
| Terragna, A | 1 |
| Rossolini, A | 1 |
| Cellesi, C | 1 |
| Figura, N | 1 |
| Barberi, A | 1 |
| Calvin-Preval, MC | 1 |
| Sander, J | 2 |
| Midtvedt, T | 2 |
26 other studies available for sulfamethoxazole and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Quantitative assessment of the effects of sulfamethoxazole on Toxoplasma gondii loads in susceptible WT C57BL/6 mice as an immunocompetent host model.
Topics: Animals; Brain; Coccidiostats; Disease Models, Animal; DNA, Protozoan; Heart; Immunocompetence; Lung | 2016 |
[PCR in evaluating the effect of allicin and its combination with SMZco on murine toxoplamosis].
Topics: Animals; Anti-Infective Agents; Disulfides; DNA, Protozoan; Drug Synergism; Drug Therapy, Combinatio | 2003 |
Evaluation of the effects of sulfamethoxazole on Toxoplasma gondii loads and stage conversion in IFN-gamma knockout mice using QC-PCR.
Topics: Animals; Disease Models, Animal; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Knockout; Revers | 2004 |
Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice.
Topics: Animals; Anti-Infective Agents; Chorioretinitis; DNA, Protozoan; Female; Interferon-gamma; Male; Mic | 2006 |
Medical management of Toxoplasma meningitis in a white-throated capuchin (Cebus capucinus).
Topics: Animals; Antiprotozoal Agents; Cebus; Clindamycin; Female; Meningitis; Monkey Diseases; Sulfamethoxa | 2006 |
[Therapeutic future of trimethoprim-sulfamethoxazole in toxoplasmosis].
Topics: Animals; Drug Combinations; Female; Humans; Mice; Pregnancy; Sulfamethoxazole; Toxoplasmosis; Toxopl | 1983 |
[Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole].
Topics: Animals; Clindamycin; Drug Combinations; Leucomycins; Mice; Pyrimethamine; Sulfadoxine; Sulfamethoxa | 1984 |
Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Leucomyci | 1983 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Respons | 1994 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons | 1998 |
[Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
Topics: Animals; Antiprotozoal Agents; Brain; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; | 1997 |
Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models.
Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation; Mice; Sulfamethoxazole; Toxoplasm | 1999 |
The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
Topics: Administration, Oral; Animals; Culture Techniques; Dose-Response Relationship, Drug; Drug Therapy, C | 1979 |
A comparative study of some combined treatment regimens in acute toxoplasmosis in mice.
Topics: Acute Disease; Animals; Clindamycin; Drug Therapy, Combination; Humans; Leucomycins; Mice; Pyrimetha | 1978 |
[A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
Topics: Animals; Injections, Subcutaneous; Leucomycins; Mice; Pyrimethamine; Sulfameter; Sulfamethazine; Sul | 1978 |
[Experimental studies on the effect of the combination sulfamoxole/trimethoprim on the Toxoplasma infection of the mouse (author's transl)].
Topics: Animals; Drug Combinations; Mice; Sulfamethoxazole; Sulfamoxole; Toxoplasmosis, Animal; Trimethoprim | 1976 |
Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
Topics: Animals; Drug Combinations; Drug Evaluation; Female; Mice; Pyrimethamine; Sulfadiazine; Sulfamethoxa | 1975 |
Trimethoprim-sulfamethoxazole in murine toxoplasmosis.
Topics: Animals; Drug Therapy, Combination; Mice; Sulfamethoxazole; Toxoplasmosis, Animal; Trimethoprim | 1976 |
The effect of some drugs on acute toxoplasmosis in mice.
Topics: Animals; Chloroquine; Clindamycin; Drug Combinations; Levamisole; Mice; Praziquantel; Sulfamethoxazo | 1989 |
Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
Topics: Animals; Antibodies; Birth Weight; Congenital Abnormalities; Delivery, Obstetric; Drug Combinations; | 1985 |
Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
Topics: Animals; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leuco | 1985 |
[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Topics: Aminobenzoates; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Syn | 1973 |
Activity of the combination trimethoprim-sulfamethoxazole on experimental toxoplasmosis.
Topics: Animals; Drug Combinations; Fluorescent Antibody Technique; Histocytochemistry; Liver; Mice; Succina | 1973 |
[The trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice].
Topics: Animals; Mice; Sulfamethoxazole; Toxoplasmosis, Animal; Trimethoprim | 1973 |
The effect of trimethoprim on acute experimental toxoplasmosis in mice.
Topics: Animals; Carrier State; Drug Synergism; Female; Male; Mice; Pyrimidines; Sulfamethoxazole; Time Fact | 1970 |
Development of sulphonamide resistance in Toxoplasma gondii.
Topics: Animals; Drug Resistance, Microbial; Female; Male; Mice; Sulfamethoxazole; Toxoplasma; Toxoplasmosis | 1971 |